Skip to content

New Harbor Capital Portfolio Company Monroe Biomedical Research Hires CFO

New Harbor Capital branded teal private equity investments icon private equity news

New Harbor Capital is excited to announce that portfolio company Monroe Biomedical Research (“MBR”, “the Company”), a clinical trial site business with a track record of recruiting diverse patient populations for complex clinical trials, has hired Matt Vaccariello as Chief Financial Officer.

Monroe Biomedical Research was founded in 2015 by Suvi Gross, Ben Karsai, and Dr. Greg Feldman, and is headquartered outside of Charlotte in Monroe, North Carolina. The Company has a history of success in meeting sponsor goals in a wide range of clinical trials, including investigations into treatments for pulmonary, metabolic, cardiological, psychiatric, and infectious diseases, as well as vaccine studies.

“We are very excited to have a leader of Matt’s caliber joining the Monroe Biomedical Research team,” said Bo Mlnarik, Principal at New Harbor Capital. “His extensive financial and operational leadership will help accelerate MBR’s continued growth and transformation into a leading clinical trial site network.”

Matt Vaccariello, Chief Financial Officer of Monroe Biomedical Research.

Matt Vaccariello, Chief Financial Officer, Monroe Biomedical Research

Matt Vaccariello brings over 16 years of strategy, operations, and finance experience to his position as Chief Financial Officer of Monroe Biomedical Research. His expertise is in leading diverse teams through organizational transformation.

Most recently, Matt served as CFO at Enlivant, a private equity-backed senior living company operating over 200 Assisted Living and Memory Care communities across 26 states. He led the company’s finance function, including financial planning and reporting, treasury, M&A, AR/AP, investor relations, and revenue management. Prior to that, he served as Enlivant’s Senior Vice President of Corporate Operations, managing a series of shared services departments, including business operations, asset management, facilities management, procurement, and dining services.

Prior to his time at Enlivant, he led business planning, analysis, and strategy teams at TJX Companies Inc., the Fortune 100 owner of TJ Maxx, Marshalls, and HomeGoods. Matt started his career in debt underwriting at CIT Group and management consulting with L.E.K. Consulting.

About Monroe Biomedical Research

Founded in 2015, Monroe Biomedical Research (MBR) is a private clinical trial facility headquartered in Monroe, North Carolina. MBR has a track record of achieving top enrollment in a diverse array of clinical trials, including studies investigating treatments for pulmonary, metabolic, cardiological, psychiatric, and infectious diseases, as well as vaccine studies for preventing infectious diseases. MBR is led by two industry-leading Principal Investigators with a combined 10-plus years in clinical research and a strong site management team. For more information, visit